Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Drug Discovery Informatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global drug discovery informatics market grew at a CAGR of around 10% during 2015-2020. Looking forward, IMARC Group expects the market to continue its strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modeling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug discovery informatics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on workflow, function, mode and end user.

Breakup by Workflow:

  • Drug Discovery
  • Drug Development
     

Breakup by Function:

  • Sequence Analysis Platforms
  • Molecular Modeling
  • Molecular Docking
  • Clinical Trial Data Management
  • Others
     

Breakup by Mode:

  • Outsourced
  • In-house
     

Breakup by End User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organization (CROs)
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Workflow, Function, Mode, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug discovery informatics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the workflow?
  • What is the breakup of the market based on the function?
  • What is the breakup of the market based on the mode?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug discovery informatics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Drug Discovery Informatics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Workflow
    6.1    Drug Discovery
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Drug Development
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Function
    7.1    Sequence Analysis Platforms
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Molecular Modeling
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Molecular Docking
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Clinical Trial Data Management
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Mode
    8.1    Outsourced
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    In-house
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by End User
    9.1    Pharmaceutical Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Biotechnology Companies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Contract Research Organization (CROs)
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
            10.3.3.1 Market Trends
            10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Accenture PLC
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Certara
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Charles River Laboratories Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Collaborative Drug Discovery Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    Eurofins DiscoverX Products
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Infosys Ltd.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    International Business Machines Corporation
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Jubilant Biosys Limited
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Oracle Corporation
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    PerkinElmer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Selvita
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
        15.3.12    Thermo Fisher Scientific Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2020
Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2020
Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2020
Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2020
Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2020
Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Drug Discovery Informatics (Molecular Modeling) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Drug Discovery Informatics (Molecular Modeling) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2020
Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million US$), 2021-2026
Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million US$), 2021-2026
Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million US$), 2021-2026
Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
Table 8: Global: Drug Discovery Informatics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links